Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.

Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation. - JSCT-ATLL12

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009251

Enrollment

Registered

2012-11-02

Start date

2013-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult T-cell leukemia-lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Overall Survivalat 1 year after relapse	—

Countries

Japan

Outcome results